We have made two corrections to the published manuscript. (1) The original image of “Control” in Figure 4b was mistakenly inserted. The corrected Figure 4b is shown here. (2) The fluorescent tag of the CD44 antibody in Figures 2e and 4a,b is PerCP/Cy5.5 but was mislabeled as “PE: CD44” at the bottom of these three figure panels. The labels have been corrected to read “PerCP/Cy5.5: CD44”. The “CD44-PE (IM7)” in the eighth line of the “Materials and Methods - Flow Cytometric Analysis and Antibodies” section should be accordingly corrected to read “CD44-PerCP/Cy5.5 (IM7)”. Figure 2. (e) Quantification of CD44⁺CD62L⁺ cells (TCM) in sorted CD8⁺ T cells that were cultured in RPMI1640 medium (Control) and RPMI1640 medium mixed with 0.5% (w/v) or 1% (w/v) alginate for 48 h, respectively. Figure 4. (a) TCM proportions in CD8⁺ T cells cultured in RPMI1640 medium (Control), RPMI1640 medium mixed with 3.5% (w/v) glucan, or RPMI1640 medium mixed with 1% (w/v) alginate for 48 h. There is no significant difference in viscosity between 3.5% (w/v) glucan and 1% (w/v) alginate-containing mediums. (b, c) TCM proportions in CD8⁺ T cells cultured for 48 h in RPMI1640 medium (Control), RPMI1640 medium containing mannuronic acid (100 μg/mL), RPMI1640 medium containing guluronic acid (100 μg/mL), or RPMI1640 medium mixed with 1% (w/v) alginate. The corrections do not affect the interpretation or the conclusions of this article. We apologize for these errors and any confusion this might have been caused. This article has not yet been cited by other publications. Figure 2. (e) Quantification of CD44⁺CD62L⁺ cells (TCM) in sorted CD8⁺ T cells that were cultured in RPMI1640 medium (Control) and RPMI1640 medium mixed with 0.5% (w/v) or 1% (w/v) alginate for 48 h, respectively. Figure 4. (a) TCM proportions in CD8⁺ T cells cultured in RPMI1640 medium (Control), RPMI1640 medium mixed with 3.5% (w/v) glucan, or RPMI1640 medium mixed with 1% (w/v) alginate for 48 h. There is no significant difference in viscosity between 3.5% (w/v) glucan and 1% (w/v) alginate-containing mediums. (b, c) TCM proportions in CD8⁺ T cells cultured for 48 h in RPMI1640 medium (Control), RPMI1640 medium containing mannuronic acid (100 μg/mL), RPMI1640 medium containing guluronic acid (100 μg/mL), or RPMI1640 medium mixed with 1% (w/v) alginate.

中文翻译：

---

对“藻酸盐通过促进细胞抗氧化作用增强抗肿瘤CD8 ⁺ T细胞的记忆特性”的更正

我们对已出版的手稿做了两个更正。（1）图4b中“控件”的原始图像被错误地插入。此处显示了校正后的图4b。（2）图2e和4a，b中CD44抗体的荧光标记是PerCP / Cy5.5，但在这三个图的底部被错误地标记为“ PE：CD44”。标签已经更正为“ PerCP / Cy5.5：CD44”。“材料和方法-流式细胞术分析和抗体”部分第八行中的“ CD44-PE（IM7）”应相应更正为“ CD44-PerCP / Cy5.5（IM7）”。图2.（e）定量的CD8 ⁺中CD44 ⁺ CD62L ⁺细胞（TCM）的定量在分别与0.5％（w / v）或1％（w / v）海藻酸盐混合的RPMI1640培养基（对照）和RPMI1640培养基中培养的T细胞分别培养48小时。图4.（a）在RPMI1640培养基（对照），与3.5％（w / v）葡聚糖混合的RPMI1640培养基或与1％（w / v）海藻酸盐混合的RPMI1640培养基中培养48 h的CD8 ⁺ T细胞中的TCM比例。在3.5％（w / v）葡聚糖和1％（w / v）含藻酸盐的培养基之间，粘度没有显着差异。（b，c）CD8 ^+中的中医比例在RPMI1640培养基（对照），含有甘露糖醛酸（100μg/ mL）的RPMI1640培养基，含有古洛糖醛酸（100μg/ mL）的RPMI1640培养基或与1％（w / v）海藻酸盐混合的RPMI1640培养基中培养48小时的T细胞。更正不影响本文的解释或结论。对于这些错误以及可能造成的任何困惑，我们深表歉意。本文尚未被其他出版物引用。图2.（e）定量的CD8 ⁺ T细胞中CD44 ⁺ CD62L ⁺细胞（TCM ）的定量，这些细胞在RPMI1640培养基（对照）和RPMI1640培养基中混合0.5％（w / v）或1％（w / v）培养）分别处理48小时。图4.（a）CD8 ⁺中药的比例在RPMI1640培养基（对照），与3.5％（w / v）葡聚糖混合的RPMI1640培养基或与1％（w / v）藻酸盐混合的RPMI1640培养基中培养T细胞48小时。在3.5％（w / v）葡聚糖和1％（w / v）含藻酸盐的培养基之间，粘度没有显着差异。（b，c）在RPMI1640培养基（对照），含甘露糖醛酸（100μg/ mL）的RPMI1640培养基，含古洛糖醛酸（100μg/ mL）的RPMI1640培养基或RPMI1640培养基中培养48小时的CD8 ⁺ T细胞中的中药比例与1％（w / v）海藻酸盐混合。